[HTML][HTML] Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

R Ewaisha, KS Anderson - Frontiers in Bioengineering and …, 2023 - frontiersin.org
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

[HTML][HTML] Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

R Ewaisha, KS Anderson - Frontiers in Bioengineering and …, 2023 - ncbi.nlm.nih.gov
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

R Ewaisha, K Anderson - Frontiers in Bioengineering and …, 2023 - europepmc.org
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

R Ewaisha, KS Anderson - Frontiers in Bioengineering and …, 2023 - par.nsf.gov
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation

R Ewaisha, KS Anderson - Frontiers in Bioengineering and …, 2023 - asu.elsevierpure.com
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

Immunogenicity of CRISPR therapeutics-Critical considerations for clinical translation

R Ewaisha, KS Anderson - Frontiers in bioengineering …, 2023 - pubmed.ncbi.nlm.nih.gov
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …

Immunogenicity of CRISPR therapeutics-Critical considerations for clinical translation.

R Ewaisha, KS Anderson - Frontiers in Bioengineering and …, 2023 - europepmc.org
CRISPR offers new hope for many patients and promises to transform the way we think of
future therapies. Ensuring safety of CRISPR therapeutics is a top priority for clinical …